DE68923862T2 - Diagnostika für den infektiösen Katzen-Bauchfellentzündungsvirus. - Google Patents

Diagnostika für den infektiösen Katzen-Bauchfellentzündungsvirus.

Info

Publication number
DE68923862T2
DE68923862T2 DE68923862T DE68923862T DE68923862T2 DE 68923862 T2 DE68923862 T2 DE 68923862T2 DE 68923862 T DE68923862 T DE 68923862T DE 68923862 T DE68923862 T DE 68923862T DE 68923862 T2 DE68923862 T2 DE 68923862T2
Authority
DE
Germany
Prior art keywords
fipv
diagnostics
peritonitis virus
proteins
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68923862T
Other languages
English (en)
Other versions
DE68923862D1 (de
Inventor
Beverly Dale
Miles Yamanaka
William N Acree
Lloyd G Chavez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
Scios Nova Inc
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Nova Inc, American Home Products Corp filed Critical Scios Nova Inc
Application granted granted Critical
Publication of DE68923862D1 publication Critical patent/DE68923862D1/de
Publication of DE68923862T2 publication Critical patent/DE68923862T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE68923862T 1988-12-30 1989-12-29 Diagnostika für den infektiösen Katzen-Bauchfellentzündungsvirus. Expired - Lifetime DE68923862T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29252788A 1988-12-30 1988-12-30

Publications (2)

Publication Number Publication Date
DE68923862D1 DE68923862D1 (de) 1995-09-21
DE68923862T2 true DE68923862T2 (de) 1996-02-08

Family

ID=23125039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68923862T Expired - Lifetime DE68923862T2 (de) 1988-12-30 1989-12-29 Diagnostika für den infektiösen Katzen-Bauchfellentzündungsvirus.

Country Status (12)

Country Link
US (2) US5780266A (de)
EP (1) EP0376744B1 (de)
JP (1) JP2903129B2 (de)
AT (1) ATE126537T1 (de)
AU (1) AU640356B2 (de)
CA (1) CA2005291C (de)
DE (1) DE68923862T2 (de)
DK (1) DK174187B1 (de)
ES (1) ES2078246T3 (de)
GR (1) GR3017770T3 (de)
IE (1) IE67650B1 (de)
NZ (1) NZ231850A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
ATE256746T1 (de) * 1991-04-25 2004-01-15 Akzo Nobel Nv Subeinheits-impfstoff gegen hundecoronavirus
EP0524672A1 (de) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV-Impfstoff
JPH07504897A (ja) * 1992-02-18 1995-06-01 パーヘリオン　コーポレーション ネコ感染性腹膜炎ワクチンおよび調製方法
JP3245169B2 (ja) * 1992-05-08 2002-01-07 ファイザー・インコーポレイテッド イヌ・コロナウイルスｓ遺伝子およびその使用
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
WO1998027433A1 (en) * 1996-12-18 1998-06-25 Engene Biotechnologies, Inc A specific diagnostic for antibodies to feline infectious peritonitis virus
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
US8541003B2 (en) 2003-06-20 2013-09-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
RU2480756C2 (ru) * 2011-02-10 2013-04-27 Государственное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ прогнозирования течения послеоперационного периода у больных с перитонитом
US10801070B2 (en) 2013-11-25 2020-10-13 The Broad Institute, Inc. Compositions and methods for diagnosing, evaluating and treating cancer
US11725237B2 (en) 2013-12-05 2023-08-15 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
CN106456724A (zh) 2013-12-20 2017-02-22 博德研究所 使用新抗原疫苗的联合疗法
EP3234130B1 (de) 2014-12-19 2020-11-25 The Broad Institute, Inc. Verfahren zum profiling vom t-zell-rezeptor-repertoire
EP3234193B1 (de) 2014-12-19 2020-07-15 Massachusetts Institute of Technology Molekulare biomarker für krebsimmuntherapie
TWI806815B (zh) 2015-05-20 2023-07-01 美商博德研究所有限公司 共有之ｇａｔａ３相關之腫瘤特異性新抗原
TW202241500A (zh) 2015-06-09 2022-11-01 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
WO2017184590A1 (en) 2016-04-18 2017-10-26 The Broad Institute Inc. Improved hla epitope prediction
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
US20220062394A1 (en) 2018-12-17 2022-03-03 The Broad Institute, Inc. Methods for identifying neoantigens

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2962920D1 (en) * 1978-11-30 1982-07-08 Wellcome Found Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
JPS5576820A (en) * 1978-11-30 1980-06-10 Wellcome Found Feline infectious peritonitis vaccine
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
WO1987004624A1 (en) * 1986-02-06 1987-08-13 Schering Corporation Feline infectious peritonitis vaccine
EP0264979A1 (de) * 1986-09-05 1988-04-27 Duphar International Research B.V Proteine und Peptide, wirksam wie Antigen und Impfstoffe gegen das infektiöse Peritonitisvirus der Felides (FIPV)
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes

Also Published As

Publication number Publication date
JP2903129B2 (ja) 1999-06-07
US5780266A (en) 1998-07-14
ES2078246T3 (es) 1995-12-16
JPH02291273A (ja) 1990-12-03
NZ231850A (en) 1992-10-28
AU640356B2 (en) 1993-08-26
AU4691589A (en) 1990-07-05
DK174187B1 (da) 2002-08-26
EP0376744B1 (de) 1995-08-16
CA2005291A1 (en) 1990-06-30
DK672789A (da) 1990-07-01
US5811104A (en) 1998-09-22
ATE126537T1 (de) 1995-09-15
GR3017770T3 (en) 1996-01-31
CA2005291C (en) 1999-01-26
IE67650B1 (en) 1996-04-17
IE894222L (en) 1990-06-30
DK672789D0 (da) 1989-12-29
DE68923862D1 (de) 1995-09-21
EP0376744A1 (de) 1990-07-04

Similar Documents

Publication Publication Date Title
DE68923862T2 (de) Diagnostika für den infektiösen Katzen-Bauchfellentzündungsvirus.
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DE3752131T2 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE3886999T2 (de) Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung.
DE3481199D1 (de) Verfahren zur gewinnung von viren bzw. virusantigenen und deren anwendung in diagnose und therapie (impfstoff).
PT87375A (pt) Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koeperfluessigkeiten und mittel zu dessen durchfuehrung
ATE163050T1 (de) Nucleotidsequenzen
DE69034218D1 (de) Impfstoff und Diagnostikum für den Schweine-Cholera-Virus
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
NO20005217D0 (no) DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav
DE69531505D1 (de) Verfahren zur zellerkennung
DE3888775D1 (de) Impfstoff für den Schutz von Katzen gegen infektiöse Katzenperitonitis.
ES2092568T3 (es) Identificacion de nuevos farmacos y reactivos.
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
DE69033503D1 (de) Nukleotidsequenzen und polypeptide von pestivirus, im einzelnen vom schweine-cholera-virus
ATE256704T1 (de) Antikörper und diagnostizierverfahren zur pestivirusdiagnose
DE69023140T2 (de) Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
DE69637325D1 (de) Methode für die behandlung einer hepatitisvirusinfektion
ES2045387T3 (es) Metodo de demostrar virus de enfermedad de marek en aves de corral.
NO902491D0 (no) Proteiner, vaksiner og nukleinsyrer.
DE3778375D1 (de) Reagenzsatz, seine verwendung und diagnostisches verfahren zur bestimmung von humanen pankreasspezifischen proteinen.
RU96108623A (ru) Штамм coronavirus canine используемый для контроля иммуногенной активности вакцин и получения сывороток для лечения и диагностики коронавирусной инфекции собак
RU94026376A (ru) Набор для выявления хламидийной инфекции
TH19567B (th) รีคอมแนนท์โปรตีนของ prrsv, ชุดวินิจฉัย และวัคซีนที่มีรีคอมบิแนนท์โปรตีนของ prrsv เหล่านี้

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCIOS INC. (N.D.GES.D. STAATES DELAWARE), MOUNTAIN